Glycobiosciences, Inc.
CanadaFDA applicant, unverified
- Devices
- 4
What Glycobiosciences, Inc. makes
Glycobiosciences, Inc. manufactures topical wound care gels, including antimicrobial and bioengineered formulations designed for skin and wound treatment. Products include L.A.M. IPM Wound Gel, IPM Wound Gel Bio, and IPM Derm Gel Bio, which are intended for infection prevention and wound healing applications.
These devices are classified as Class II under FDA regulations and are listed via the 510(k) pathway. The company is based in the United States.
Catalogue
L.A.M. Ipm Wound Gel, Ipm Derm Gel Ref K130781
Regimes: 510(k) Registry: 510(k)Ipm Wound Gel Bio Ref K123193
Regimes: 510(k) Registry: 510(k)IPM Wound Gel Bio, IPM Derm Gel Bio Ref K143527
Regimes: 510(k) Registry: 510(k)L.A.M. Imp Wound Gel Ref K123113
Regimes: 510(k) Registry: 510(k)
Frequently asked questions
How many devices does Glycobiosciences, Inc. have in the registry?
The registry currently lists 4 devices for Glycobiosciences, Inc.. Devices recorded under merged duplicate company entries are counted once.
Which registries list Glycobiosciences, Inc.'s devices?
Among its 4 most recently registered devices, Glycobiosciences, Inc. has devices listed in FDA 510(k) (4 devices).
What are the newest devices from Glycobiosciences, Inc. in the registry?
The most recently registered devices listed for Glycobiosciences, Inc. include L.A.M. IPM WOUND GEL, IPM DERM GEL, IPM WOUND GEL BIO, IPM Wound Gel Bio, IPM Derm Gel Bio and L.A.M. IMP WOUND GEL.